Celltrion's Herceptin Biosimilar One Step Closer To US FDA Approval

 
• By Jung Won Shin
Celltrion Headquarters
Celltrion HQ in Incheon, South Korea • Source: Celltrion Inc.

More from Biosimilars

More from Biosimilars & Generics